Search research articles
Contact Us
Filters
Showing results (1331-1340 of 1,446) with videos related to
Page
of 145
Sort By:
Alimentary Pharmacology & Therapeutics
|
February 21, 2025
Risk of Incident Type 2 Diabetes and Prediabetes in Patients With Direct Acting Antiviral-Induced Cure of Hepatitis C Virus Infection
Yu-Ping Chang, Ji-Yuh Lee, Chi-Yi Chen, et al.
Cell Research
|
January 28, 2017
A molecular roadmap for induced multi-lineage trans-differentiation of fibroblasts by chemical combinations
Xiaoping Han, Hao Yu, Daosheng Huang, et al.
Liver Cancer
|
May 14, 2020
Baseline Mac-2 Binding Protein Glycosylation Isomer Level Stratifies Risks of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Oral Antiviral Therapy
Tai-Chung Tseng, Cheng-Yuan Peng, Yao-Chun Hsu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
February 3, 2016
A phase 3b study of sofosbuvir plus ribavirin in Taiwanese patients with chronic genotype 2 hepatitis C virus infection
Jia-Horng Kao, Rong-Nan Chien, Ting-Tsung Chang, et al.
JHEP Reports : Innovation in Hepatology
|
April 19, 2021
Whole genome deep sequencing analysis of viral quasispecies diversity and evolution in HBeAg seroconverters
Su-Ru Lin, Ta-Yu Yang, Cheng-Yuan Peng, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
December 12, 2018
Efficacy and safety of 12 weeks of daclatasvir, asunaprevir plus ribavirin for HCV genotype-1b infection without NS5A resistance-associated substitutions
Ming-Lung Yu, Chao-Hung Hung, Yi-Hsiang Huang, et al.
American Journal of Cancer Research
|
March 10, 2023
Combined CRAFITY score and α-fetoprotein response predicts treatment outcomes in patients with unresectable hepatocellular carcinoma receiving anti-programmed death-1 blockade-based immunotherapy
Wei-Fan Hsu, Hsueh-Chou Lai, Cheng-Kuo Chen, et al.
Journal of Medical Virology
|
May 15, 2024
Four weeks of off-treatment follow-up is sufficient to determine virologic responses at off-treatment week 12 in patients with hepatitis C virus infection receiving fixed-dose pangenotypic direct-acting antivirals
Chen-Hua Liu, Yu-Ping Chang, Ji-Yuh Lee, et al.
Genome Research
|
January 24, 2019
A dynamic and integrated epigenetic program at distal regions orchestrates transcriptional responses to VEGFA
Shiyan Wang, Jiahuan Chen, Sara P Garcia, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
November 17, 2020
Effect of Primary Tumor Location on Postmetastasectomy Survival in Patients with Colorectal Cancer Liver Metastasis
Tien-Hua Chen, Wei-Shone Chen, Jeng-Kai Jiang, et al.
Page
of 145
Search research articles
Search
Showing results (1331-1340 of 1,446) with videos related to
Sort By:
Page
of 145
Alimentary Pharmacology & Therapeutics
|
February 21, 2025
Risk of Incident Type 2 Diabetes and Prediabetes in Patients With Direct Acting Antiviral-Induced Cure of Hepatitis C Virus Infection
Yu-Ping Chang, Ji-Yuh Lee, Chi-Yi Chen, et al.
Cell Research
|
January 28, 2017
A molecular roadmap for induced multi-lineage trans-differentiation of fibroblasts by chemical combinations
Xiaoping Han, Hao Yu, Daosheng Huang, et al.
Liver Cancer
|
May 14, 2020
Baseline Mac-2 Binding Protein Glycosylation Isomer Level Stratifies Risks of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Oral Antiviral Therapy
Tai-Chung Tseng, Cheng-Yuan Peng, Yao-Chun Hsu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
February 3, 2016
A phase 3b study of sofosbuvir plus ribavirin in Taiwanese patients with chronic genotype 2 hepatitis C virus infection
Jia-Horng Kao, Rong-Nan Chien, Ting-Tsung Chang, et al.
JHEP Reports : Innovation in Hepatology
|
April 19, 2021
Whole genome deep sequencing analysis of viral quasispecies diversity and evolution in HBeAg seroconverters
Su-Ru Lin, Ta-Yu Yang, Cheng-Yuan Peng, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
December 12, 2018
Efficacy and safety of 12 weeks of daclatasvir, asunaprevir plus ribavirin for HCV genotype-1b infection without NS5A resistance-associated substitutions
Ming-Lung Yu, Chao-Hung Hung, Yi-Hsiang Huang, et al.
American Journal of Cancer Research
|
March 10, 2023
Combined CRAFITY score and α-fetoprotein response predicts treatment outcomes in patients with unresectable hepatocellular carcinoma receiving anti-programmed death-1 blockade-based immunotherapy
Wei-Fan Hsu, Hsueh-Chou Lai, Cheng-Kuo Chen, et al.
Journal of Medical Virology
|
May 15, 2024
Four weeks of off-treatment follow-up is sufficient to determine virologic responses at off-treatment week 12 in patients with hepatitis C virus infection receiving fixed-dose pangenotypic direct-acting antivirals
Chen-Hua Liu, Yu-Ping Chang, Ji-Yuh Lee, et al.
Genome Research
|
January 24, 2019
A dynamic and integrated epigenetic program at distal regions orchestrates transcriptional responses to VEGFA
Shiyan Wang, Jiahuan Chen, Sara P Garcia, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
November 17, 2020
Effect of Primary Tumor Location on Postmetastasectomy Survival in Patients with Colorectal Cancer Liver Metastasis
Tien-Hua Chen, Wei-Shone Chen, Jeng-Kai Jiang, et al.
Page
of 145